-
Sanofi’s Unveils Made in India Injectable Polio Vaccine
Sanofi Pasteur, the vaccines division of Sanofi, has unveiled ShanIPV, an injectable inactivated polio vaccine (IPV) manufactured by its affiliate Shantha Biotechnics, Hyderabad.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
The Ebola Vaccine, Latrogenic Injuries, and Legal Liability
Making vaccines is a risky, oftentimes unenviable business. Vaccines are administered to healthy people who tend to be unforgiving if an adverse side effect or injury subsequently develops. The risk of being sued, even when a vaccine supplier follows best practices, combined with growing anti-vaccination sentiment, creates a climate that is not conducive to vaccine innovation. The dissuasive effect of litigation risk and legal liability is heightened both for vaccines aimed at diseases of poor countries, for which the financial inducements are weak anyway [1,2], and vaccines for public health emergencies, which are developed in accelerated clinical trials that may lack the statistical power or detailed follow-up necessary to detect rare adverse effects. Yet, as the West African Ebola outbreak demonstrates, the world can ill afford not to have vaccines against diseases of poverty in emergency situations [1]. Several reasons exist for not having a vaccine available, relating to the biology of the virus and the epidemiological challenges pertaining to evaluating a vaccine for a rare disease. However, financial incentives and disincentives for vaccine manufactures to invest in vaccine trials for rare diseases in resource-poor countries also need to be considered. We argue that, as one part of a comprehensive plan to promote vaccine development, there needs to be a plan to lessen the risks of litigation and liability to remove disincentives for these vaccines to be developed and later deployed. As others point out, no satisfactory plan now exists [3].
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Can This Necklace Help More Kids Get Vaccinated?
It looks like a normal necklace. Just a small, clear plastic droplet dangling from a thick black thread.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Vaccine Deals a Blow to Meningitis A in Africa
A conjugate vaccine has led to control and near total elimination of meningitis A disease in Africa, according to studies.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
The Dream: 90 percent vaccination rate in Pakistan
Neither red tape nor Taliban has deterred Noor Rakhshani from working on a vaccine problem in her Pakistani homeland.
- Categories
- Health Care
- Region
- North Africa & Near East
- Tags
- vaccines
-
‘We’re not winning this fight’
Diarrhea – which is quite treatable – still kills 1,000 per day, and children in low- and middle-income countries continue to experience about three episodes of diarrhea each year. Repeated cases of severe diarrhea, especially during important development stages in a child’s life, can have a lasting impact on physical and cognitive growth.
- Categories
- Health Care
- Tags
- vaccines
-
BYU Researchers Develop ‘Just-Add-Water’ Method for Frozen Vaccines
Producing and distributing vaccines that protect us from life-threatening new viruses could be as simple as just adding water.
- Categories
- Health Care
-
Hilleman to Invest in R&D for Low-Cost Vaccines
While the incidence of meningitis or meningococcal disease in India is low, the available vaccine for the disease is ‘narrow’ and extremely expensive, says Davinder Gill, CEO, Hilleman Laboratories, a ‘non-profit joint venture’ between US pharma major Merck and UK-based Wellcome Trust.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.